These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 38001459)
1. Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation. Yang M; Xia L; Song J; Hu H; Zang N; Yang J; Zou Y; Wang L; Zheng X; He Q; Liu J; Liu F; Liang K; Sun L; Chen L Lipids Health Dis; 2023 Nov; 22(1):202. PubMed ID: 38001459 [TBL] [Abstract][Full Text] [Related]
2. Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease. Yang Y; Chen J; Gao Q; Shan X; Wang J; Lv Z Toxicology; 2020 Dec; 445():152599. PubMed ID: 32976958 [TBL] [Abstract][Full Text] [Related]
3. Didymin alleviates metabolic dysfunction-associated fatty liver disease (MAFLD) via the stimulation of Sirt1-mediated lipophagy and mitochondrial biogenesis. Yang JW; Zou Y; Chen J; Cui C; Song J; Yang MM; Gao J; Hu HQ; Xia LQ; Wang LM; Lv XY; Chen L; Hou XG J Transl Med; 2023 Dec; 21(1):921. PubMed ID: 38115075 [TBL] [Abstract][Full Text] [Related]
4. Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis. Guo T; Yan W; Cui X; Liu N; Wei X; Sun Y; Fan K; Liu J; Zhu Y; Wang Z; Zhang Y; Chen L Mol Med; 2023 Sep; 29(1):132. PubMed ID: 37770820 [TBL] [Abstract][Full Text] [Related]
5. Honokiol Mitigates Metabolic-Associated Fatty Liver Disease by Regulating Nrf2 and RIPK3 Signaling Pathways. Cao W; Chen Z; Lin C; Lin X; Chen Y; Zhang J Turk J Gastroenterol; 2024 Jul; 35(7):551-559. PubMed ID: 39128113 [TBL] [Abstract][Full Text] [Related]
6. Si-Ni-San Reduces Hepatic Lipid Deposition in Rats with Metabolic Associated Fatty Liver Disease by AMPK/SIRT1 Pathway. Zhang N; Liu T; Wang J; Xiao Y; Zhang Y; Dai J; Ma Z; Ma D Drug Des Devel Ther; 2023; 17():3047-3060. PubMed ID: 37808345 [TBL] [Abstract][Full Text] [Related]
7. Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis. Tong J; Lan XT; Zhang Z; Liu Y; Sun DY; Wang XJ; Ou-Yang SX; Zhuang CL; Shen FM; Wang P; Li DJ Acta Pharmacol Sin; 2023 May; 44(5):1014-1028. PubMed ID: 36323829 [TBL] [Abstract][Full Text] [Related]
8. Taohe Chengqi decoction alleviated metabolic-associated fatty liver disease by boosting branched chain amino acids catabolism in the skeletal muscles of type 2 diabetes mellitus. Yuan Z; Qiao H; Wang Z; Wang H; Han M; Zhang W; Zhou Y; Hassan HM; Zhao W; Qin T Phytomedicine; 2024 Apr; 126():155315. PubMed ID: 38387274 [TBL] [Abstract][Full Text] [Related]
9. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1. Zhang Y; Geng C; Liu X; Li M; Gao M; Liu X; Fang F; Chang Y Mol Metab; 2017 Jan; 6(1):138-147. PubMed ID: 28123944 [TBL] [Abstract][Full Text] [Related]
10. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861 [TBL] [Abstract][Full Text] [Related]
11. Cardiac sirtuin1 deficiency exacerbates ferroptosis in doxorubicin-induced cardiac injury through the Nrf2/Keap1 pathway. Wang W; Zhong X; Fang Z; Li J; Li H; Liu X; Yuan X; Huang W; Huang Z Chem Biol Interact; 2023 May; 377():110469. PubMed ID: 37030624 [TBL] [Abstract][Full Text] [Related]
12. Betulin prevents high fat diet-induced non-alcoholic fatty liver disease by mitigating oxidative stress and upregulating Nrf2 and SIRT1 in rats. Farage AE; Abdo W; Osman A; Abdel-Kareem MA; Hakami ZH; Alsulimani A; Bin-Ammar A; Alanazi AS; Alsuwayt B; Alanazi MM; Antar SA; Kamel EM; Mahmoud AM Life Sci; 2023 Jun; 322():121688. PubMed ID: 37030617 [TBL] [Abstract][Full Text] [Related]
13. Decreased autophagosome biogenesis, reduced NRF2, and enhanced ferroptotic cell death are underlying molecular mechanisms of non-alcoholic fatty liver disease. Liu P; Anandhan A; Chen J; Shakya A; Dodson M; Ooi A; Chapman E; White E; Garcia JG; Zhang DD Redox Biol; 2023 Feb; 59():102570. PubMed ID: 36495698 [TBL] [Abstract][Full Text] [Related]
14. Bioactive dipeptides mitigate high-fat and high-fructose corn syrup diet-induced metabolic-associated fatty liver disease via upregulation of Nrf2/HO-1 expressions in C57BL/6J mice. Wayal V; Hsieh CC Biomed Pharmacother; 2023 Dec; 168():115724. PubMed ID: 37852102 [TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cell-conditioned medium improved mitochondrial function and alleviated inflammation and apoptosis in non-alcoholic fatty liver disease by regulating SIRT1. Yang M; Cui Y; Song J; Cui C; Wang L; Liang K; Wang C; Sha S; He Q; Hu H; Guo X; Zang N; Sun L; Chen L Biochem Biophys Res Commun; 2021 Mar; 546():74-82. PubMed ID: 33578292 [TBL] [Abstract][Full Text] [Related]
16. Dimethyl fumarate-mediated Nrf2/ARE pathway activation and glibenclamide-mediated NLRP3 inflammasome cascade inhibition alleviate type II diabetes-associated fatty liver in rats by mitigating oxidative stress and inflammation. Dwivedi DK; Jena GB J Biochem Mol Toxicol; 2023 Jul; 37(7):e23357. PubMed ID: 36999408 [TBL] [Abstract][Full Text] [Related]
17. Limonin ameliorates acetaminophen-induced hepatotoxicity by activating Nrf2 antioxidative pathway and inhibiting NF-κB inflammatory response via upregulating Sirt1. Yang R; Song C; Chen J; Zhou L; Jiang X; Cao X; Sun Y; Zhang Q Phytomedicine; 2020 Apr; 69():153211. PubMed ID: 32259676 [TBL] [Abstract][Full Text] [Related]
18. Hesperetin ameliorates hepatic oxidative stress and inflammation Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953 [TBL] [Abstract][Full Text] [Related]
19. Quercetin alleviates kainic acid-induced seizure by inhibiting the Nrf2-mediated ferroptosis pathway. Xie R; Zhao W; Lowe S; Bentley R; Hu G; Mei H; Jiang X; Sun C; Wu Y; Yueying Liu Free Radic Biol Med; 2022 Oct; 191():212-226. PubMed ID: 36087883 [TBL] [Abstract][Full Text] [Related]
20. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]